These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32370858)

  • 21. Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.
    Mortensen MB; Falk E
    BMJ Open; 2014 Oct; 4(10):e005991. PubMed ID: 25326211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
    Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
    Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.
    Gencer B; Koskinas KC; Räber L; Karagiannis A; Nanchen D; Auer R; Carballo D; Carballo S; Klingenberg R; Heg D; Matter CM; Lüscher TF; Rodondi N; Mach F; Windecker S
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
    J Am Coll Cardiol; 2019 Jun; 73(24):3210-3227. PubMed ID: 30423394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CAD Severity on Cardiac CTA Identifies Patients With Most Benefit of Treating LDL-Cholesterol to ACC/AHA and ESC/EAS Targets.
    Mortensen MB; Steffensen FH; Bøtker HE; Jensen JM; Rønnow Sand NP; Kragholm KH; Kanstrup H; Sørensen HT; Leipsic J; Blaha MJ; Nørgaard BL
    JACC Cardiovasc Imaging; 2020 Sep; 13(9):1961-1972. PubMed ID: 32563656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology guidelines for the management of patients with non-ST-segment elevation acute coronary syndromes.
    Alame AJ; Karatasakis A; Karacsonyi J; Danek BA; Resendes E; Martinez Parachini JR; Kalsaria P; Roesle M; Rangan BV; Sorajja P; Jneid H; Banerjee S; Brilakis ES
    Coron Artery Dis; 2017 Jun; 28(4):294-300. PubMed ID: 28306587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutrition and physical activity recommendations from the United States and European cardiovascular guidelines: a comparative review.
    Ferraro RA; Fischer NM; Xun H; Michos ED
    Curr Opin Cardiol; 2020 Sep; 35(5):508-516. PubMed ID: 32649350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular risk.
    Tokgözoğlu L; Casula M; Pirillo A; Catapano AL
    Atheroscler Suppl; 2020 Dec; 42():e1-e5. PubMed ID: 33589218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
    Circulation; 2019 Jun; 139(25):e1144-e1161. PubMed ID: 30586775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile.
    Echeverría G; Dussaillant C; Villarroel L; Rigotti A
    J Clin Lipidol; 2016; 10(1):192-8.e1. PubMed ID: 26892136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transatlantic guidelines on dyslipidemia and cardiovascular risk: key differences across the pond.
    Agha AM; Virani SS; Ballantyne CM
    Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):114-121. PubMed ID: 33395089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major Global Coronary Artery Calcium Guidelines.
    Golub IS; Termeie OG; Kristo S; Schroeder LP; Lakshmanan S; Shafter AM; Hussein L; Verghese D; Aldana-Bitar J; Manubolu VS; Budoff MJ
    JACC Cardiovasc Imaging; 2023 Jan; 16(1):98-117. PubMed ID: 36599573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.
    Nayor M; Vasan RS
    Circulation; 2016 May; 133(18):1795-806. PubMed ID: 27143546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations.
    Adhyaru BB; Jacobson TA
    Curr Atheroscler Rep; 2017 Jun; 19(6):29. PubMed ID: 28500517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population.
    Mortensen MB; Nordestgaard BG
    Ann Intern Med; 2018 Jan; 168(2):85-92. PubMed ID: 29297004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in low-density lipoprotein-cholesterol blood values between 2012 and 2017 suggest sluggish adoption of the recent 2013 treatment guidelines.
    Superko HR; Williams PT; Dansinger M; Schaefer E
    Clin Cardiol; 2019 Jan; 42(1):101-110. PubMed ID: 30444024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
    Pavlović J; Greenland P; Deckers JW; Kavousi M; Hofman A; Ikram MA; Franco OH; Leening MJ
    Eur J Prev Cardiol; 2018 Mar; 25(4):420-431. PubMed ID: 29171772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.